Among the key genes related to inflammatory responses, CD74, the HLA-DR antigen-associated invariant chain, is reported to exhibit dual oncogenic and tumor-suppressive roles depending on the cancer type and specific microenvironment. This evidence concerns the gene CD74 and neoplasm.